Oxana Beskrovnaya

Oxana Beskrovnaya

Company: Dyne Therapeutics

Job title: Chief Scientific Officer

Seminars:

DYNE-101 & DYNE-251: Moving From Bench to Clinic to Deliver Potentially Transformative Therapies in DM1 & DMD 9:00 am

Sharing how the FORCETM platform harnesses the natural expression of transferrin receptor 1 (TfR1) on muscle cells for targeted delivery of rationally selected payload with the goal of addressing the underlying causes of rare and genetic muscle diseases Discussing robust data using multiple preclinical models to validate the two lead FORCE conjugates, DYNE-101 and DYNE-251…Read more

day: Scientific Program Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.